Provision of Cryptococcal Antigen Lateral Flow Assay (LFA) kits for rapid and accurate detection of Cryptococcal disease (CD) in a national reflexed program and diagnostic purposes through CD4 and microbiology laboratories of the NHLS for a period of five (5) years.